70 related articles for article (PubMed ID: 27049080)
1. Expression of cartilage antitumor component RanBP9 in osteosarcoma.
Zhu LL; Wang CH; Yang HP; Shu WH
J Biol Regul Homeost Agents; 2016; 30(1):103-10. PubMed ID: 27049080
[TBL] [Abstract][Full Text] [Related]
2. RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma.
Dai H; Lv YF; Yan GN; Meng G; Zhang X; Guo QN
Cell Death Dis; 2016 Dec; 7(12):e2572. PubMed ID: 28032865
[TBL] [Abstract][Full Text] [Related]
3. Tagging enhances histochemical and biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin.
Soliman SHA; Stark AE; Gardner ML; Harshman SW; Breece CC; Amari F; Orlacchio A; Chen M; Tessari A; Martin JA; Visone R; Freitas MA; La Perle KMD; Palmieri D; Coppola V
Sci Rep; 2020 Apr; 10(1):7138. PubMed ID: 32346083
[TBL] [Abstract][Full Text] [Related]
4. Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells.
Palmieri D; Scarpa M; Tessari A; Uka R; Amari F; Lee C; Richmond T; Foray C; Sheetz T; Braddom A; Burd CE; Parvin JD; Ludwig T; Croce CM; Coppola V
Oncotarget; 2016 Apr; 7(14):18371-83. PubMed ID: 26943034
[TBL] [Abstract][Full Text] [Related]
5. Mind Bomb-Binding Partner RanBP9 Plays a Contributory Role in Retinal Development.
Yoo KW; Thiruvarangan M; Jeong YM; Lee MS; Maddirevula S; Rhee M; Bae YK; Kim HG; Kim CH
Mol Cells; 2017 Apr; 40(4):271-279. PubMed ID: 28359144
[TBL] [Abstract][Full Text] [Related]
6. Scorpins in the DNA Damage Response.
Palmieri D; Tessari A; Coppola V
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914204
[TBL] [Abstract][Full Text] [Related]
7. RanBP9 Plays a Critical Role in Neonatal Brain Development in Mice.
Palavicini JP; Lloyd BN; Hayes CD; Bianchi E; Kang DE; Dawson-Scully K; Lakshmana MK
PLoS One; 2013; 8(6):e66908. PubMed ID: 23840553
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.
Nagao-Kitamoto H; Setoguchi T; Kitamoto S; Nakamura S; Tsuru A; Nagata M; Nagano S; Ishidou Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S
Cancer Lett; 2015 Jan; 356(2 Pt B):855-61. PubMed ID: 25449781
[TBL] [Abstract][Full Text] [Related]
9. RanBP9 overexpression reduces dendritic arbor and spine density.
Wang H; Lewsadder M; Dorn E; Xu S; Lakshmana MK
Neuroscience; 2014 Apr; 265():253-62. PubMed ID: 24486966
[TBL] [Abstract][Full Text] [Related]
10. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
11. RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells.
Puverel S; Kiris E; Singh S; Klarmann KD; Coppola V; Keller JR; Tessarollo L
Oncotarget; 2016 Dec; 7(51):85109-85123. PubMed ID: 27835883
[TBL] [Abstract][Full Text] [Related]
12. CLOCK interacts with RANBP9 and is involved in alternative splicing in spermatogenesis.
Yang J; Zhang Z; Zhang Y; Zheng X; Lu Y; Tao D; Liu Y; Ma Y
Gene; 2018 Feb; 642():199-204. PubMed ID: 29126923
[TBL] [Abstract][Full Text] [Related]
13. The expression of TSSC3 and its prognostic value in patients with osteosarcoma.
Wang X; He H; Zhang K; Peng W
Biomed Pharmacother; 2016 Apr; 79():23-6. PubMed ID: 27044808
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
15. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
16. Investigating the potential genetic association between RANBP9 polymorphisms and the risk of schizophrenia.
Bae JS; Kim JY; Park BL; Cheong HS; Kim JH; Namgoong S; Kim JO; Park CS; Kim BJ; Lee CS; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
Mol Med Rep; 2015 Apr; 11(4):2975-80. PubMed ID: 25482375
[TBL] [Abstract][Full Text] [Related]
17. Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation.
Rex EB; Rankin ML; Yang Y; Lu Q; Gerfen CR; Jose PA; Sibley DR
Mol Pharmacol; 2010 Jul; 78(1):69-80. PubMed ID: 20395553
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression and purification of the low-complexity region of RanBP9 protein.
Dhakal S; Sapkota K; Huang F; Rangachari V
Protein Expr Purif; 2020 Aug; 172():105630. PubMed ID: 32217127
[TBL] [Abstract][Full Text] [Related]
19. RAN-binding protein 9 is involved in alternative splicing and is critical for male germ cell development and male fertility.
Bao J; Tang C; Li J; Zhang Y; Bhetwal BP; Zheng H; Yan W
PLoS Genet; 2014 Dec; 10(12):e1004825. PubMed ID: 25474150
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
